Does Rallies show Form 4 insider transactions for AVNS?

Yes. Rallies tracks AVNS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is AVNS research on Rallies investment advice?

No. Rallies provides research, data, and educational context for AVNS. It does not provide personalized investment advice.

AVNS (Avanos Medical, Inc.) Stock Analysis - Insider Trades

Avanos Medical, Inc. (AVNS) is a publicly traded Healthcare sector company. As of May 21, 2026, AVNS trades at $24.74 with a market cap of $1.16B and a P/E ratio of -2.90. AVNS moved -0.04% today. Year to date, AVNS is +118.74%; over the trailing twelve months it is +88.86%. Its 52-week range spans $9.30 to $24.91. Rallies surfaces AVNS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading AVNS stock inside the company?

Recent AVNS insider activity includes Holbrook Kerr sold 13.83K, Holbrook Kerr sold 100, Holbrook Kerr sold 761, Holbrook Kerr sold 305, and BLACKFORD GARY bought 20.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

AVNS Key Metrics

Key financial metrics for AVNS
Metric	Value
Price	$24.74
Market Cap	$1.16B
P/E Ratio	-2.90
EPS	$-8.53
Dividend Yield	0.00%
52-Week High	$24.91
52-Week Low	$9.30
Volume	0
Avg Volume	0
Revenue (TTM)	$687.80M
Net Income	$-392.10M
Gross Margin	55.44%

Recent AVNS Insider Trades

Holbrook Kerr sold 13.83K (~$152.17K) on Nov 18, 2025.
Holbrook Kerr sold 100 (~$1.10K) on Nov 18, 2025.
Holbrook Kerr sold 761 (~$8.38K) on Nov 18, 2025.
Holbrook Kerr sold 305 (~$3.36K) on Nov 18, 2025.
BLACKFORD GARY bought 20.00K (~$219.50K) on Aug 13, 2025.

Latest AVNS News

Avanos Medical Agrees to $1.272B Buyout, Q1 Sales Rise 8.8% — May 5, 2026
Avanos Medical $25 Cash Sale Spurs Legal Probe Over Potential Fiduciary Breaches — Apr 23, 2026
Avanos Medical’s Q4 EPS Tops Estimate by 20.8%, Shares Slide 10% — Feb 25, 2026
Avanos Medical 2025 Sales Climb 1.9% to $701M, Plans $20M Cost Savings — Feb 24, 2026

AVNS Analyst Consensus

AVNS analyst coverage data. Average price target: $0.00.

Common questions about AVNS

Who is trading AVNS stock inside the company?: Recent AVNS insider activity includes Holbrook Kerr sold 13.83K, Holbrook Kerr sold 100, Holbrook Kerr sold 761, Holbrook Kerr sold 305, and BLACKFORD GARY bought 20.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for AVNS?: Yes. Rallies tracks AVNS insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is AVNS research on Rallies investment advice?: No. Rallies provides research, data, and educational context for AVNS. It does not provide personalized investment advice.